EXHIBIT 10.42 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • September 18th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
Contract Type FiledSeptember 18th, 1997 Company Industry Jurisdiction
ARTICLE 1 DEFINITIONSLicense Agreement • September 18th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
Contract Type FiledSeptember 18th, 1997 Company Industry Jurisdiction
ASSIGNMENT OF LICENSE AND RESTATED LICENSE AGREEMENTLicense Agreement • September 18th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Connecticut
Contract Type FiledSeptember 18th, 1997 Company Industry Jurisdiction
1 EXHIBIT 10.40 THE CONFIDENTIAL PORTION OF THIS CONTRACT HAS BEEN OMITTED PURSUANT TO REGULATION 240.25B-2(B) OF THE SECURITIES EXCHANGE ACT OF 1934, AND HAS BEEN FILED SEPARATELY WITH THE COMMISSION. AMENDED AND RESTATED LICENSE AGREEMENT This...License Agreement • September 18th, 1997 • Ribozyme Pharmaceuticals Inc • Pharmaceutical preparations • Colorado
Contract Type FiledSeptember 18th, 1997 Company Industry Jurisdiction